ReviewPharmaceuticals (Basel, Switzerland)2023

The Disruption of NMDAR/TRPM4 Death Signaling with TwinF Interface Inhibitors: A New Pharmacological Principle for Neuroprotection.

Jing Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.